Abstract Buffalo, NY, December 3, 2018 - Tactiva Therapeutics, development stage immuno-oncology company with a unique approach to adoptive T-cell therapy, announced today it has secured a $35 million Series ...
Abstract Buffalo, NY based Tactiva Therapeutics, Inc. announced they’ve licensed new intellectual property from the Roswell Park Cancer Institute Corporation that covers the use of the Oncolytic Vaccinia Virus (OVV) ...
Abstract BUFFALO, N.Y., October 16, 2018 -- Tactiva Therapeutics, a development stage company targeting a broad range of cancers, announced today that its co-founder Kunle Odunsi, M.D., Ph.D., FRCOG, FACOG, ...
BUFFALO, N.Y.(WKBW) – Lieutenant Governor Kathy Hochul, Dr. Candace Johnson and a special team of doctors at Roswell Park announced the launch of a new innovative Immunotherapy Biotech Company called, Tactiva Therapeutics in front of a packed house inside Roswell’s Research Center.
Tactiva will develop the latest science to lead even more effective approaches at fighting and treating the most aggressive forms of cancer. In addition, …